Mrv0541 08291310042D 20 21 0 0 0 0 999 V2000 6.9263 -17.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9263 -18.6206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.2118 -17.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2118 -19.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4973 -17.7957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4973 -18.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6407 -17.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.3550 -17.7957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.6407 -16.5583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.0695 -17.3831 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 9.7839 -17.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0695 -16.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7839 -16.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7839 -15.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4983 -16.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4984 -14.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2128 -16.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2128 -15.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7839 -18.6206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.4983 -17.3831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 2 0 0 0 0 4 2 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 6 5 2 0 0 0 0 1 7 1 0 0 0 0 7 8 1 0 0 0 0 7 9 2 0 0 0 0 10 8 1 1 0 0 0 10 11 1 0 0 0 0 10 12 1 0 0 0 0 14 13 1 0 0 0 0 15 13 2 0 0 0 0 16 14 2 0 0 0 0 17 15 1 0 0 0 0 18 16 1 0 0 0 0 18 17 2 0 0 0 0 12 13 1 0 0 0 0 11 19 2 0 0 0 0 11 20 1 0 0 0 0 M END > DBMET01063 > drugbank > NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1 > InChI=1S/C14H14N4O2/c15-13(19)11(8-10-4-2-1-3-5-10)18-14(20)12-9-16-6-7-17-12/h1-7,9,11H,8H2,(H2,15,19)(H,18,20)/t11-/m0/s1 > KTQJEBWLYWKXRA-NSHDSACASA-N > C14H14N4O2 > 270.2866 > 270.111675712 > 4 > 34 > -8.039223364717852e-08 > 26.590658985989506 > 1 > 2 > 0 > 1 > (2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamide > 0.25 > -0.10580104766666679 > -3.06 > 0 > 0 > 2 > 0 > 15.339972291985498 > 13.55850217145414 > -0.5857954113795487 > 97.97 > 72.367 > 5 > 1 > 2.38e-01 g/l > biotin > 0 > DBMET01063 > Bortezomib metabolite M3 > N46QC2PY7V $$$$